CTW-23497-86621
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 365 / AL
- Registered
- 2021-08-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-15
Registered in v-safe
-
2021-08-15
Dose 1 — Pfizer-BioNTech
- 2021-08-15
-
2021-08-16
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Heat/warmth around injection siteMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-29
-
2021-09-05
Dose 2 — Pfizer-BioNTech
- 2021-09-05
-
2021-09-06
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Loss of personal independence in daily activities — Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Very dizzy and lightheaded - Moderate symptom thy has limited my daily activities somewhatMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-07
- 2021-09-08
- 2021-09-09
- 2021-09-10
-
2021-09-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-12
-
2021-09-19
Survey response — day 14, dose 2MedDRA: Photopsia, Visual impairment, Vitreous floaters — Feeling: GoodFree text: On three separate occasions since the second shot I have experienced a weird vision problem - like moving, squiggly lines made of bright sparks in the periphery of my vision. Each time last only for 4-5 seconds. I have never had that before.MedDRA releases: 2024-11 · check-in free text available
- 2021-09-26
- 2021-10-05
- 2021-10-10
- 2021-10-17
- 2021-12-05
- 2022-03-08
- 2022-09-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-15 | Pfizer-BioNTech | No |
| 2 | 2021-09-05 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Heat/warmth around injection site
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Very dizzy and lightheaded - Moderate symptom thy has limited my daily activities somewhat
Release 9 — day 14, dose 2
Symptoms: On three separate occasions since the second shot I have experienced a weird vision problem - like moving, squiggly lines made of bright sparks in the periphery of my vision. Each time last only for 4-5 seconds. I have never had that before.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Photopsia | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SD | Vitreous floaters | · | · | ✓ |
| SRO | Dizziness | ✓ | · | ✓ |
| SRO | Injection site warmth | ✓ | · | ✓ |
| SRO | Loss of personal independence in daily activities | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release